Fitzsimon_menu

Eye on innovators.

Each month, we feature an innovator who is making advances in health and care through the work they do here on the Fitzsimons Innovation Community campus.

THIS MONTH’S FEATURE

Unlocking the Power of Real-World Clinical Data & Single-Cell Multi-omics to Accelerate Breakthroughs in Precision Medicine

RefinedScience team of experts in clinical medicine, molecular and cellular biology, data science and pharma turn insights into advancements in care. Through the power of big data, single cell omics and AI RefinedScience aim to identify effective therapies, diagnostics and other key breakthroughs and deliver them to the patients who need them the most.
Read More

Previous Innovation Spotlights:

Unlocking the Power of Real-World Clinical Data & Single-Cell Multi-omics to Accelerate Breakthroughs in Precision Medicine
November 22, 2024

Unlocking the Power of Real-World Clinical Data & Single-Cell Multi-omics to Accelerate Breakthroughs in Precision Medicine

RefinedScience team of experts in clinical medicine, molecular and cellular biology, data science and pharma turn insights into advancements in care. Through the power of big data, single cell omics and AI RefinedScience aim to identify effective therapies, diagnostics and other key breakthroughs and deliver them to the patients who need them the most.

READ MORE

CPC Clinical Research: Transforming Clinical Trials
October 14, 2024

CPC Clinical Research: Transforming Clinical Trials

CPC Clinical Research (CPC) is an academic research organization recognized for its expertise in comprehensive clinical trial design and management for both national and international clinical research. CPC is a leader in innovative, efficient, and pragmatic approaches to clinical trials, implementation science, and real-world evidence studies. The team leads clinical scientific programs including clinical trials providing full service and a global reach.

READ MORE

Lohocla Research Corporation: Transforming Lives for Sufferers of Chronic Pain, Neurodegenerative Disease, and Addictive Disorders
September 09, 2024

Lohocla Research Corporation: Transforming Lives for Sufferers of Chronic Pain, Neurodegenerative Disease, and Addictive Disorders

Lohocla Research Corporation conceptualizes novel solutions for difficult medical problems like chronic pain, neurodegenerative disease, and addictive disorders by employing an iconoclastic approach. Deep experience undergirds the scientific expertise of the company’s executive scientists. To date, Lohocla Research has brought two first-in-class small-molecule drugs to first-in-human trials: Kindolor and Nezavist.

READ MORE

OncoVerity: Fighting Cancer with Data and Wisdom
August 20, 2024

OncoVerity: Fighting Cancer with Data and Wisdom

OncoVerity is a cutting-edge biotech company using a computational biology platform to better the lives of patients battling cancer. OncoVerity is addressing a fundamental challenge in cancer treatment—the diverse nature of cancer cells—by using single-cell analysis technology and machine learning to advance transformative cancer therapies.

READ MORE

EnteroTrack: Empowering Patients to Take Control of Chronic Upper GI Health
July 09, 2024

EnteroTrack: Empowering Patients to Take Control of Chronic Upper GI Health

EnteroTrack produces EnteroTracker®, a simple-to-use, inexpensive device to sample the upper gastrointestinal (GI) system in children and adults without the need for endoscopy. Screening or monitoring the upper GI tract is important to catch diseases early such as esophageal cancer or to control chronic conditions such as Eosinophilic Esophagitis (EoE).

READ MORE

GelSana: Making a Material Impact on Advancing Wound Care
June 11, 2024

GelSana: Making a Material Impact on Advancing Wound Care

GelSana engineers highly elastic wound dressing polymers which stretch and conform across any wound, reduce inflammation through polymer chemistry, prevent infection, and provide sustained drug delivery over time.

READ MORE